Edition:
United States

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

73.44USD
25 May 2017
Change (% chg)

-- (--)
Prev Close
$73.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
598,979
52-wk High
$85.46
52-wk Low
$62.80

Latest Key Developments (Source: Significant Developments)

Cardinal Health board approved 3 pct increase in qtrly dividend
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Cardinal Health Inc ::Cardinal Health -board of directors approved a 3 percent increase in company's quarterly dividend from $0.4489 per share to $0.4624 per share.  Full Article

Cardinal Health says generic pricing definitely getting better
Monday, 1 May 2017 09:29am EDT 

May 1 (Reuters) - Cardinal Health :Ceo says "experiencing pricing deflation in generics, some heightened reimbursement pressures which affect our customers"-conf call.Cardinal health says generic pricing definitely getting better, not quite as good as the company modeled but definitely getting better - conf call.  Full Article

Cardinal Health Q3 non-gaap EPS $1.53
Monday, 1 May 2017 07:00am EDT 

May 1 (Reuters) - Cardinal Health Inc :Cardinal health reports third-quarter results for fiscal year 2017.Q3 revenue $31.8 billion.Q3 gaap earnings per share $1.20.Cardinal health inc- third-quarter revenue for pharmaceutical segment increased 3 percent to $28.4 billion.Q3 earnings per share view $1.46, revenue view $32.30 billion -- Thomson Reuters I/B/E/S.Cardinal health - reaffirms expectation that 2017 non-gaap eps from continuing operations will be at bottom of previous guidance range$5.35-$5.50.Fy2017 earnings per share view $5.36 -- Thomson Reuters I/B/E/S.Q3 non-gaap earnings per share $1.53.  Full Article

Cardinal Health updates fiscal 2017 guidance
Tuesday, 18 Apr 2017 06:56am EDT 

April 18 (Reuters) - Cardinal Health Inc :Cardinal Health updates fiscal 2017 guidance; provides early outlook for future fiscal years.Cardinal Health Inc says in addition, fiscal 2019 non-GAAP EPS is expected to grow at least high-single digits versus fiscal 2018.Sees fiscal 2018 view is for non-GAAP EPS to be flat to down mid-single digits..Cardinal Health - now believes fiscal 2017 non-GAAP EPS from continuing operations will be at bottom of its previous guidance range of $5.35 to $5.50.Cardinal Health - expects generic deflation to moderate to mid-single digits in 2018, the deflation is still headwind for pharmaceutical segment for year.  Full Article

Medtronic to divest part of its unit to Cardinal Health for $6.1 bln
Tuesday, 18 Apr 2017 06:55am EDT 

April 18 (Reuters) - Medtronic Plc ::Medtronic signs definitive agreement to divest a portion of its patient monitoring & recovery division to Cardinal Health for $6.1 billion.Medtronic Plc - transaction is expected to result in an immediate positive impact to medtronic's comparable, constant currency revenue growth rate.Medtronic Plc - deal expected to result in modest dilution on a net basis to co's FY 2018 non-gaap earnings per share in range of about $0.12 to $0.18.Medtronic Plc - deal to result in immediate positive impact to co's non-gaap comparable, constant currency operating margin of about 50 basis points.Medtronic Plc - intends to allocate $1 billion of after-tax proceeds for incremental share repurchases in FY18.Medtronic Plc - transaction also will include 17 dedicated manufacturing facilities.Medtronic - among product lines included in deal are co's dental/animal health, chart paper, wound care, incontinence, electrodes, sharpsafety offerings.Medtronic Plc - Medtronic will retain its respiratory & monitoring solutions business as well as its renal care solutions business.Medtronic - among product lines included in deal are co's thermometry, perinatal protection, blood collection, compression, enteral feeding offerings.  Full Article

Cardinal Health to acquire patient product portfolio from Medtronic for $6.1 bln
Tuesday, 18 Apr 2017 06:55am EDT 

April 18 (Reuters) - Cardinal Health Inc :Cardinal Health to acquire leading patient product portfolio from Medtronic for $6.1 billion in cash.Cardinal Health Inc - purchase price does not include cash tax benefits of at least $100 million.Cardinal Health Inc - acquisition is expected to be financed with a combination of $4.5 billion in new senior unsecured notes and existing cash.Cardinal Health Inc - purchase price for deal does not include cash tax benefits of at least $100 million.Says by end of fiscal 2020, company assumes synergies will exceed $150 million annually.Cardinal Health - expects acquisition to be accretive to non-GAAP earnings per share from continuing operations by more than $0.21 per share in fiscal 2018.Cardinal Health plans to issue long-term debt to finance transaction.Cardinal Health Inc - company expects acquisition to be accretive to non-GAAP diluted earnings per share by more than $0.55 per share in fiscal 2019.Goldman Sachs Bank USA and Goldman Sachs Lending Partners Llc to provide a $4.5 billion unsecured bridge loan.Cardinal Health - once deal is complete, patient care, deep vein thrombosis & nutritional insufficiency units to become part of Cardinal Health's medical unit.  Full Article

Cardinal Health files for potential mixed shelf, size undisclosed - SEC filing
Tuesday, 7 Feb 2017 05:20pm EST 

Cardinal Health Inc :Files for potential mixed shelf, size undisclosed - SEC filing.  Full Article

Cardinal Health reports Q2 EPS $1.02
Tuesday, 7 Feb 2017 07:00am EST 

Cardinal Health Inc - : Second-quarter revenue for pharmaceutical segment increased 5 percent to $29.7 billion . Having completed more than half its fiscal year, company is adjusting its fiscal year 2017 guidance range for non-gaap diluted EPS . Cardinal Health reports second-quarter results for fiscal year 2017 . Q2 revenue $33.1 billion versus I/B/E/S view $33.55 billion . Sees fy 2017 non-gaap earnings per share $5.35 to $5.50 from continuing operations . Q2 gaap earnings per share $1.02 . Q2 earnings per share view $1.23 -- Thomson Reuters I/B/E/S . Pricing in generic pharmaceutical market was a significant headwind for pharmaceutical segment profit and enterprise operating earnings .Q2 non-gaap diluted EPS attributable to Cardinal Health Inc $1.34.  Full Article

Cardinal Health reaches settlement with West Virginia
Monday, 9 Jan 2017 02:09pm EST 

Cardinal Health Inc : Cardinal health reaches settlement with West Virginia . Cardinal health has agreed to pay $20 million to state of West Virginia to resolve issues . West Virginia has released company from any further actions .settlement resolving lawsuit filed in 2012 regarding co's distribution of controlled substances in west virginia between 2007-2012.  Full Article

Cardinal Health Inc says announces civil settlement with DOJ
Friday, 23 Dec 2016 11:15am EST 

Cardinal Health Inc - : Cardinal Health Inc says announces civil settlement with DOJ . Cardinal Health -Reached nationwide settlement with federal government, resolving outstanding civil penalty portion of co's 2012 administrative settlement with U.S. DEA . Cardinal Health Inc - Under settlement, cardinal health has agreed to pay $44 million to Department of Justice (DOJ) to resolve matter .Cardinal Health Inc says DOJ, amongst others, agreed to take no further administrative or civil action on these and related matters.  Full Article

More From Around the Web

BRIEF-Cardinal Health board approved 3 pct increase in qtrly dividend

* Cardinal Health -board of directors approved a 3 percent increase in company's quarterly dividend from $0.4489 per share to $0.4624 per share Source text for Eikon: Further company coverage: